Literature DB >> 11399041

A high-throughput screen for identifying transmembrane pore-forming peptides.

J M Rausch1, W C Wimley.   

Abstract

We have developed a visual microwell plate assay for rapid, high-throughput screening for membrane-disrupting molecules such as de novo designed pore formers, antibiotic peptides, bacterial toxins, and lipases. The detectability is based on the strong fluorescence emission of the lanthanide metal terbium(III) (Tb(3+)) when it interacts with the aromatic chelator dipicolinic acid (DPA). While Tb(3+) is not strongly fluorescent alone, the binary complex emits bright green fluorescence when irradiated with uv light. For the microwell plate assay, we prepared unilamellar phospholipid vesicles that had either Tb(3+) or DPA entrapped and the opposite molecule in the external solution. Disruption of the membranes allows the Tb(3+)/DPA complex to form, giving rise to a visibly fluorescent solution. In plates with 20-microl wells, the lower limit of visual detectability of the Tb(3+)/DPA complex in solution was about 2.5 microM. The lower limit of detectability using vesicles with entrapped Tb(3+) or DPA was about 50 microM phospholipid. We show that the membrane-disrupting effect of as little as 0.25 microM or 5 pmol of the pore-forming, antibiotic peptide alamethicin can be detected visually with this system. This sensitive, high-throughput assay is readily automatable and makes possible the visual screening of combinatorial peptide libraries for members that permeabilize lipid bilayer membranes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399041     DOI: 10.1006/abio.2001.5137

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

1.  High-throughput discovery of broad-spectrum peptide antibiotics.

Authors:  Ramesh Rathinakumar; William C Wimley
Journal:  FASEB J       Date:  2010-04-21       Impact factor: 5.191

2.  Rational combinatorial design of pore-forming beta-sheet peptides.

Authors:  Joshua M Rausch; Jessica R Marks; William C Wimley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

3.  Determining the mechanism of membrane permeabilizing peptides: identification of potent, equilibrium pore-formers.

Authors:  Aram J Krauson; Jing He; William C Wimley
Journal:  Biochim Biophys Acta       Date:  2012-07

4.  Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein.

Authors:  Bruno Sainz; Joshua M Rausch; William R Gallaher; Robert F Garry; William C Wimley
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Determining the Effects of Membrane-Interacting Peptides on Membrane Integrity.

Authors:  William C Wimley
Journal:  Methods Mol Biol       Date:  2015

6.  Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity.

Authors:  Ramesh Rathinakumar; William F Walkenhorst; William C Wimley
Journal:  J Am Chem Soc       Date:  2009-06-10       Impact factor: 15.419

7.  Beta-sheet pore-forming peptides selected from a rational combinatorial library: mechanism of pore formation in lipid vesicles and activity in biological membranes.

Authors:  Joshua M Rausch; Jessica R Marks; Ramesh Rathinakumar; William C Wimley
Journal:  Biochemistry       Date:  2007-10-06       Impact factor: 3.162

8.  Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes.

Authors:  Ramesh Rathinakumar; William C Wimley
Journal:  J Am Chem Soc       Date:  2008-07-09       Impact factor: 15.419

Review 9.  Mechanistic Landscape of Membrane-Permeabilizing Peptides.

Authors:  Shantanu Guha; Jenisha Ghimire; Eric Wu; William C Wimley
Journal:  Chem Rev       Date:  2019-01-09       Impact factor: 72.087

10.  Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein.

Authors:  Joshua M Costin; Joshua M Rausch; Robert F Garry; William C Wimley
Journal:  Virol J       Date:  2007-11-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.